CLINICAL TRIAL OF MANAGEMENT STRATEGIES OF ATRIAL FIBRILLATION IN ANELDERLY POPULATION



NIH GUIDE, Volume 23, Number 18, May 13, 1994



RFP AVAILABLE:  NHLBI-HC-94-22



P.T. 34



Keywords:

  Cardiovascular Diseases 

  Clinical Trial 



National Heart, Lung, and Blood Institute



The National Heart, Lung, and Blood Institute is soliciting proposals

for a clinical trial center to study two different strategies for the

management of atrial fibrillation.  The contractor will enroll

approximately 5,300 patients to be randomized to one of the two

management strategies.  The first strategy will administer arrhythmia

drugs to maintain normal sinus rhythm and the second group will be

given a different group of drugs and/or catheter ablation for heart

rate control only.  The anticipated period of performance is seven

years beginning on or about April 1, 1995.  The Request for Proposal

(RFP) NHLBI-HC-94-22 will be released on or about May 10, 1994 with

proposals due on August 1, 1994.  One award is anticipated from this

RFP.



INQUIRIES



All requests must be in writing, cite RFP NHLBI-HC-94-22, and be

addressed to:



Ms. Lisa O'Neill

Contracting Officer

ECA Contract Section

National Heart, Lung, and Blood Institute

7550 Wisconsin Avenue, Room 200

Bethesda, MD  20892



.

Return to 1994 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)